ANDA 73541, held by Tp Anda Holdings. Cyclobenzaprine Hydrochloride.
As of Nov 16, 2026, ANDA 73541 (Cyclobenzaprine Hydrochloride), held by Tp Anda Holdings, was first approved by FDA on May 23, 1995, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 23, 1995 | Original application | Approved | None posted |
| Cyclobenzaprine Hydrochloride10MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Apr 11, 2013 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 6, 2006 | Supplement 6Manufacturing | Approved | None posted |
| Apr 6, 2006 | Supplement 7Labeling | Approved | None posted |
| Aug 19, 2005 | Supplement 5Labeling | Approved | None posted |
| Dec 1, 1998 | Supplement 1Manufacturing | Approved | None posted |
| May 23, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters